Protease-activated receptor-1: Key player in the sepsis coagulation-inflammation crosstalk

Critical Care

Volumn 17, Issue 1, 2013, Pages

  Asehnoune, Karim ^a   Moine, Pierre ^b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

BACTERIAL LOAD; BLOOD CLOTTING; DISEASE EXACERBATION; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; LEUKOCYTE; LUNG INJURY; MACROPHAGE; MOLECULAR INTERACTION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; SEPSIS; SEPTIC SHOCK; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTE; ANIMAL; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; PNEUMONIA, PNEUMOCOCCAL; RECEPTOR, PAR-1;

EID: 84874229158     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12502     Document Type: Note

References (12)

1. Schouten M, van't Veer C, Roelofs JJ, Levi M, van der Poll T. Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study. Crit Care 2012, 16:R238. 10.1186/cc11910, 23270594.
2. Adams MN, Ramachandran R, Yau M-K, Suen JY, Fairlie DP, Hollenberg MD, Hooper JD. Structure, function and pathophysiology of protease activated receptors. Pharmacol Ther 2011, 130:248-282. 10.1016/j.pharmthera.2011.01.003, 21277892.
3. Petäjä J. Inflammation and coagulation. An overview. Thromb Res 2011, 127(Suppl 2):S34-S37.
4. Peters T, Henry PJ. Protease-activated receptors and prostaglandins in inflammatory lung disease. Br J Pharmacol 2009, 158:1017-1033. 10.1111/j.1476-5381.2009.00449.x, 2785524, 19845685.
5. van der Poll T, Levi M. Crosstalk between inflammation and coagulation: the lessons of sepsis. Curr Vasc Pharmacol 2012, 10:632-638. 10.2174/157016112801784549, 22272914.
6. Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B. PAR1 contributes to influenza A virus pathogenicity in mice. J Clin Invest 2013, 123:206-214. 10.1172/JCI61667, 3533265, 23202729.
7. Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ, Davis GE, Chambers RC, Matthay MA, Sheppard D. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006, 116:1606-1614. 10.1172/JCI27183, 1462943, 16710477.
8. Mercer PF, Deng X, Chambers RC. Signaling pathways involved in proteinase-activated receptor1-induced proinflammatory and profibrotic mediator release following lung injury. Ann N Y Acad Sci 2007, 1096:86-88. 10.1196/annals.1397.073, 17405919.
9. Chen D, Carpenter A, Abrahams J, Chambers RC, Lechler RI, McVey JH, Dorling A. Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo. J Exp Med 2008, 205:1739-1746. 10.1084/jem.20071427, 2525584, 18606855.
10. Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, Petersson F, Price JE, Schroit A, Prieto VG, Hung M-C, Bar-Eli M. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem 2009, 284:28845-28855. 10.1074/jbc.M109.042150, 2781430, 19703903.
11. Rijneveld AW, Weijer S, Florquin S, Speelman P, Shimizu T, Ishii S, van der Poll T. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice. J Infect Dis 2004, 189:711-716. 10.1086/381392, 14767826.
12. Almansa R, Wain J, Tamayo E, Andaluz-Ojeda D, Martin-Loeches I, Ramirez P, Bermejo-Martin JF. Immunological monitoring to prevent and treat sepsis. Crit Care 2013, 17:109. 10.1186/cc11922, 23351425.